ResearcherShanghai Jiao Tong UniversityActive in the last 2 years

Jianjun Liu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0288-647X; OpenAlex author ID A5100439769. Sources: ClinicalTrials.gov.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 1
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2023: 1 paper · 2024: 1 trial

Papers 1

Relationship between the expression of PD-L1 and 18F-FDG uptake in pancreatic ductal adenocarcinoma. Last author DOI 10.1038/s41416-023-02297-9 ↗

Trials 1

ImmunoPET Imaging of Pancreatic Cancer Study chair NCT06602037 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Weijun Wei · 1 shared trial, 2024 · strength 0.68
- Trial ImmunoPET Imaging of Pancreatic Cancer NCT06602037 ↗
Qing Xia · 1 shared paper, 2023 · strength 0.17
- Paper Relationship between the expression of PD-L1 and 18F-FDG uptake in pancreatic ductal adenocarcinoma. DOI 10.1038/s41416-023-02297-9 ↗
Jiajin Li · 1 shared paper, 2023 · strength 0.17
- Paper Relationship between the expression of PD-L1 and 18F-FDG uptake in pancreatic ductal adenocarcinoma. DOI 10.1038/s41416-023-02297-9 ↗
Ruohua Chen · 1 shared paper, 2023 · strength 0.17
- Paper Relationship between the expression of PD-L1 and 18F-FDG uptake in pancreatic ductal adenocarcinoma. DOI 10.1038/s41416-023-02297-9 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.